Adocia Past Earnings Performance

Past criteria checks 0/6

Adocia's earnings have been declining at an average annual rate of -14.4%, while the Biotechs industry saw earnings growing at 16.9% annually. Revenues have been declining at an average rate of 34.4% per year.

Key information

-14.4%

Earnings growth rate

-11.8%

EPS growth rate

Biotechs Industry Growth11.5%
Revenue growth rate-34.4%
Return on equityn/a
Net Margin-189.5%
Next Earnings Update27 Feb 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Adocia makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:ADOCP Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2311-2100
31 Mar 2314-1400
31 Dec 2217-700
30 Sep 2216-700
30 Jun 2214-800
31 Mar 2210-1500
31 Dec 216-2300
30 Sep 216-2200
30 Jun 216-2200
31 Mar 216-2300
31 Dec 207-2300
30 Sep 207-2000
30 Jun 207-1800
31 Mar 208-1800
31 Dec 198-1900
30 Sep 1915-1700
30 Jun 1923-1600
31 Mar 1938-400
31 Dec 1854800
30 Sep 1847100
30 Jun 1840-500
31 Mar 1834-700
31 Dec 1727-900
30 Sep 1732-300
30 Jun 1738300
31 Mar 1734-200
31 Dec 1630-800
30 Sep 1637-300
30 Jun 1644200
31 Mar 1644700
31 Dec 15451300
30 Sep 1532200
30 Jun 1519-800
31 Mar 1512-1500
31 Dec 144-2100
30 Sep 146-1300
30 Jun 148-500
31 Mar 148-500
31 Dec 139-400
30 Sep 137-700
30 Jun 136-900
31 Mar 137-700

Quality Earnings: ADOCP is currently unprofitable.

Growing Profit Margin: ADOCP is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ADOCP is unprofitable, and losses have increased over the past 5 years at a rate of 14.4% per year.

Accelerating Growth: Unable to compare ADOCP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ADOCP is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-26.8%).


Return on Equity

High ROE: ADOCP's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/02/03 02:01
End of Day Share Price 2023/11/06 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Adocia SA is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eric Le BerrigaudBryan Garnier & Co
Peter WelfordJefferies LLC
Seamus FernandezLeerink Partners LLC